Improving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors.
Kuritzky
L
L
Department of Community Health and Family Practice, University of Florida College of Medicine, Gainesville, USA.
Samraj
G
G
Quillen
D M
DM
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D020909:Acarbose / Q000494:pharmacology / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D005944:Glucosamine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D050112:Imino Pyranoses
D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D050112:Imino Pyranoses; C045621:miglitol; D017485:1-Deoxynojirimycin; D005944:Glucosamine; D020909:Acarbose